AHC
GILD icon

Adell Harriman & Carpenter’s Gilead Sciences GILD Stock Holding History

Adell Harriman & Carpenter’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,780
Closed -$350K – 162
2024
Q1 		$350K Sell
4,780
-1,213
-20% -$93.3K 0.03% 138
2023
Q4 		$485K Sell
5,993
-1,300
-18% -$101K 0.04% 117
2023
Q3 		$547K Sell
7,293
-200
-3% -$15.4K 0.06% 115
2023
Q2 		$575K Sell
7,493
-25
-0.3% -$1.99K 0.06% 122
2023
Q1 		$624K Sell
7,518
-10
-0.1% -$828 0.07% 118
2022
Q4 		$646K Buy
7,528
+1,300
+21% +$103K 0.07% 117
2022
Q3 		$384K Buy
6,228
+200
+3% +$12.6K 0.05% 135
2022
Q2 		$373K Buy
6,028
+322
+6% +$19.9K 0.05% 117
2022
Q1 		$339K Sell
5,706
-3,300
-37% -$211K 0.03% 145
2021
Q4 		$654K Buy
9,006
+65
+0.7% +$4.48K 0.06% 119
2021
Q3 		$625K Buy
8,941
+800
+10% +$56.2K 0.07% 119
2021
Q2 		$561K Buy
8,141
+100
+1% +$6.68K 0.06% 124
2021
Q1 		$520K Buy
8,041
+3,700
+85% +$239K 0.06% 114
2020
Q4 		$253K Buy
4,341
+400
+10% +$24.1K 0.03% 142
2020
Q3 		$249K Sell
3,941
-350
-8% -$24.3K 0.04% 136
2020
Q2 		$330K Sell
4,291
-735
-15% -$56.3K 0.06% 105
2020
Q1 		$376K Buy
5,026
+720
+17% +$49.8K 0.08% 101
2019
Q4 		$280K Sell
4,306
-165
-4% -$10.7K 0.05% 129
2019
Q3 		$283K Buy
4,471
+595
+15% +$38.9K 0.05% 124
2019
Q2 		$262K Sell
3,876
-420
-10% -$27.6K 0.05% 119
2019
Q1 		$279K Sell
4,296
-3,016
-41% -$200K 0.05% 125
2018
Q4 		$457K Sell
7,312
-265
-3% -$18.5K 0.1% 116
2018
Q3 		$585K Sell
7,577
-715
-9% -$54K 0.11% 113
2018
Q2 		$587K Sell
8,292
-737
-8% -$52K 0.12% 113
2018
Q1 		$681K Buy
9,029
+45
+0.5% +$3.58K 0.14% 102
2017
Q4 		$644K Sell
8,984
-1,250
-12% -$94.9K 0.14% 99
2017
Q3 		$829K Buy
10,234
+136
+1% +$10.4K 0.18% 91
2017
Q2 		$715K Sell
10,098
-17,653
-64% -$1.17M 0.16% 96
2017
Q1 		$1.88M Sell
27,751
-10,464
-27% -$736K 0.43% 64
2016
Q4 		$2.74M Sell
38,215
-3,330
-8% -$248K 0.68% 54
2016
Q3 		$3.29M Sell
41,545
-16,675
-29% -$1.35M 0.83% 48
2016
Q2 		$4.86M Buy
58,220
+726
+1% +$64.4K 1.27% 33
2016
Q1 		$5.28M Sell
57,494
-3,989
-6% -$360K 1.42% 29
2015
Q4 		$6.22M Buy
61,483
+1,611
+3% +$168K 1.67% 16
2015
Q3 		$5.88M Buy
59,872
+789
+1% +$87.6K 1.73% 13
2015
Q2 		$6.92M Buy
59,083
+4,259
+8% +$465K 1.78% 16
2015
Q1 		$5.38M Buy
54,824
+6,545
+14% +$665K 1.42% 24
2014
Q4 		$4.55M Sell
48,279
-3,276
-6% -$339K 1.24% 27
2014
Q3 		$4.27M Hold
51,555
– – 1.18% 29
2014
Q2 		$4.27M Buy
51,555
+8,675
+20% +$675K 1.18% 29
2014
Q1 		$3.04M Buy
42,880
+9,695
+29% +$760K 0.9% 42
2013
Q4 		$2.49M Buy
33,185
+2,550
+8% +$178K 0.77% 44
2013
Q3 		$1.93M Buy
30,635
+5,800
+23% +$347K 0.54% 50
2013
Q2 		$1.27M Buy
+24,835
New +$1.29M 0.46% 58

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adell Harriman & Carpenter's GILD Position: Q2 2024 in Review

Adell Harriman & Carpenter sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 4,780 shares — an estimated $350K sold.

Adell Harriman & Carpenter first reported a position in GILD in Q2 2013 and held it in 44 quarters. The position peaked at $6.92M in Q2 2015. 1,679 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Adell Harriman & Carpenter reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • Adell Harriman & Carpenter sold 4,780 Gilead Sciences shares in Q2 2024, an estimated $350K.
  • Adell Harriman & Carpenter first reported a position in Gilead Sciences in Q2 2013 and held it in 44 quarters.
  • Adell Harriman & Carpenter's Gilead Sciences position peaked at $6.92M in Q2 2015.
  • 1,679 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Adell Harriman & Carpenter's 13F filing for Q2 2024, filed 1 Aug 2024.